AXGN insider transaction filings
Axogen, Inc. — 50 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-08-12. Screen AXGN transaction legs live →
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-12 | 4 | Wendell Amy McBride — Director | Option exercise (M): 13,353 @ $14.85 · Sale (S): 13,353 @ $48.42 · Option exercise (M): 13,353 (derivative) @ $0 | EDGAR |
| 2026-08-12 | 4 | Began Marc A — EVP & General Counsel | Option exercise (M): 67,500 @ $8.16 · Sale (S): 67,500 @ $47.34 · Option exercise (M): 67,500 (derivative) @ $0 | EDGAR |
| 2026-08-11 | 4 | Weiler Kathy Johnson — Director | Sale (S): 14,150 @ $45.30 | EDGAR |
| 2026-06-26 | 4 | Weiler Kathy Johnson — Director | Grant/award (A): 4,392 (derivative) @ $0 | EDGAR |
| 2026-06-26 | 4 | TYNDALL JOSEPH A. — Director | Grant/award (A): 4,392 (derivative) @ $0 | EDGAR |
| 2026-06-26 | 4 | Levine Alan M — Director | Grant/award (A): 4,392 (derivative) @ $0 | EDGAR |
| 2026-06-26 | 4 | Burke William P. Mr. — Director | Grant/award (A): 4,392 (derivative) @ $0 | EDGAR |
| 2026-06-26 | 4 | JOHNSON JOHN — Director | Grant/award (A): 4,392 (derivative) @ $0 | EDGAR |
| 2026-06-26 | 4 | Wendell Amy McBride — Director | Grant/award (A): 4,392 (derivative) @ $0 | EDGAR |
| 2026-06-26 | 4 | THOMAS PAUL — Director | Grant/award (A): 5,579 (derivative) @ $0 | EDGAR |
| 2026-06-23 | 4 | Weiler Kathy Johnson — Director | Option exercise (M): 14,150 @ $0 · Option exercise (M): 14,150 (derivative) @ $0 | EDGAR |
| 2026-06-23 | 4 | TYNDALL JOSEPH A. — Director | Option exercise (M): 14,150 @ $0 · Option exercise (M): 14,150 (derivative) @ $0 | EDGAR |
| 2026-06-23 | 4 | Levine Alan M — Director | Option exercise (M): 14,150 @ $0 · Option exercise (M): 14,150 (derivative) @ $0 | EDGAR |
| 2026-06-23 | 4 | Burke William P. Mr. — Director | Option exercise (M): 14,150 @ $0 · Option exercise (M): 14,150 (derivative) @ $0 | EDGAR |
| 2026-06-23 | 4 | JOHNSON JOHN — Director | Option exercise (M): 14,150 @ $0 · Option exercise (M): 14,150 (derivative) @ $0 | EDGAR |
| 2026-06-23 | 4 | Wendell Amy McBride — Director | Option exercise (M): 14,150 @ $0 · Option exercise (M): 14,150 (derivative) @ $0 | EDGAR |
| 2026-06-23 | 4 | THOMAS PAUL — Director | Option exercise (M): 18,867 @ $0 · Option exercise (M): 18,867 (derivative) @ $0 | EDGAR |
| 2026-05-12 | 4 | Wendell Amy McBride — Director | Option exercise (M): 1,647 @ $14.85 · Sale (S): 1,647 @ $42.60 · Option exercise (M): 1,647 (derivative) @ $0 | EDGAR |
| 2026-05-08 | 4 | Quackenbush Doris — Sales VP | Sale (S): 3,878 @ $43.51 | EDGAR |
| 2026-05-08 | 4 | Hartley Lindsey Marie — CFO | Option exercise (M): 2,500 @ $8.20 · Sale (S): 478 @ $43.67 · Option exercise (M): 2,963 @ $8.27 · Sale (S): 573 @ $43.67 · Option exercise (M): 2,500 (derivative) @ $0 · Option exercise (M): 2,963 (derivative) @ $0 | EDGAR |
| 2026-05-08 | 4 | Kemp Jens — Chief Marketing Officer | Sale (S): 4,000 @ $43.44 | EDGAR |
| 2026-05-08 | 4 | Weiler Kathy Johnson — Director | Option exercise (M): 16,344 @ $6.95 · Sale (S): 16,344 @ $44.09 · Option exercise (M): 16,344 (derivative) @ $0 | EDGAR |
| 2026-05-08 | 4 | JOHNSON JOHN — Director | Option exercise (M): 11,050 @ $7.04 · Sale (S): 11,050 @ $43.26 · Option exercise (M): 11,050 (derivative) @ $0 | EDGAR |
| 2026-03-18 | 4 | Hartley Lindsey Marie — CFO | Option exercise (M): 4,000 @ $0 · Tax withholding (F): 1,574 @ $32.84 · Option exercise (M): 5,000 @ $0 · Tax withholding (F): 1,968 @ $32.84 · Option exercise (M): 4,000 (derivative) @ $0 · Option exercise (M): 5,000 (derivative) @ $0 | EDGAR |
| 2026-03-18 | 4 | DeVinney Erick Wayne — Chief Innovation Officer | Option exercise (M): 6,363 @ $0 · Tax withholding (F): 2,870 @ $32.84 · Option exercise (M): 11,575 @ $0 · Sale (S): 5,221 @ $32.84 · Option exercise (M): 6,363 (derivative) @ $0 · Option exercise (M): 11,575 (derivative) @ $0 | EDGAR |
| 2026-03-02 | 4 | Kemp Jens — Chief Marketing Officer | Grant/award (A): 50,670 @ $0 · Tax withholding (F): 15,414 @ $31.90 · Tax withholding (F): 2,952 @ $30.65 · Grant/award (A): 23,000 (derivative) @ $0 | EDGAR |
| 2026-03-02 | 4 | Began Marc A — EVP & General Counsel | Grant/award (A): 33,780 @ $0 · Tax withholding (F): 8,753 @ $31.90 · Option exercise (M): 11,250 @ $0 · Tax withholding (F): 4,427 @ $30.65 · Grant/award (A): 23,000 (derivative) @ $0 · Option exercise (M): 11,250 (derivative) @ $0 | EDGAR |
| 2026-03-02 | 4 | DeVinney Erick Wayne — Chief Innovation Officer | Grant/award (A): 33,780 @ $0 · Tax withholding (F): 10,702 @ $31.90 · Tax withholding (F): 11,276 @ $30.65 · Grant/award (A): 23,000 (derivative) @ $0 | EDGAR |
| 2026-02-27 | 4 | Hartley Lindsey Marie — CFO | Grant/award (A): 17,453 @ $0 · Tax withholding (F): 6,630 @ $31.90 · Grant/award (A): 23,000 (derivative) @ $0 | EDGAR |
| 2026-02-27 | 4 | DALE MICHAEL D — Chief Executive Officer | Grant/award (A): 98,000 (derivative) @ $0 | EDGAR |
| 2026-02-24 | 4 | Hartley Lindsey Marie — CFO | Grant/award (A): 17,500 @ $0 · Tax withholding (F): 6,704 @ $35.38 · Grant/award (A): 17,500 (derivative) @ $0 | EDGAR |
| 2025-12-17 | 4 | Hartley Lindsey Marie — CFO | Option exercise (M): 14,812 @ $8.27 · Sale (S): 14,812 @ $29.86 · Option exercise (M): 14,812 (derivative) @ $0 | EDGAR |
| 2025-12-17 | 4 | Weiler Kathy Johnson — Director | Option exercise (M): 18,248 @ $7.04 · Option exercise (M): 21,825 @ $6.95 · Sale (S): 18,248 @ $29.55 · Sale (S): 21,825 @ $29.55 · Sale (S): 6,580 @ $29.55 · Option exercise (M): 18,248 (derivative) @ $0 · +1 more | EDGAR |
| 2025-12-17 | 4 | Wendell Amy McBride — Director | Option exercise (M): 5,000 @ $8.95 · Option exercise (M): 20,436 @ $6.30 · Option exercise (M): 18,248 @ $7.04 · Sale (S): 5,000 @ $29.31 · Sale (S): 20,436 @ $29.31 · Sale (S): 18,248 @ $29.31 · +3 more | EDGAR |
| 2025-12-12 | 4 | Began Marc A — EVP & General Counsel | Sale (S): 13,222 @ $30 | EDGAR |
| 2025-12-12 | 4 | DALE MICHAEL D — Chief Executive Officer | Sale (S): 25,000 @ $30 | EDGAR |
| 2025-12-10 | 4 | Hartley Lindsey Marie — CFO | Option exercise (M): 20,000 @ $15.22 · Option exercise (M): 5,000 @ $8.20 · Sale (S): 11,533 @ $31.56 · Sale (S): 2,854 @ $31.56 · Option exercise (M): 20,000 (derivative) @ $0 · Option exercise (M): 5,000 (derivative) @ $0 | EDGAR |
| 2025-12-10 | 4 | Kemp Jens — Chief Marketing Officer | Sale (S): 8,156 @ $31.21 | EDGAR |
| 2025-12-10 | 4 | TYNDALL JOSEPH A. — Director | Option exercise (M): 14,248 @ $7.04 · Option exercise (M): 10,860 @ $10.95 · Sale (S): 14,248 @ $30.98 · Sale (S): 10,860 @ $30.98 · Option exercise (M): 14,248 (derivative) @ $0 · Option exercise (M): 10,860 (derivative) @ $0 | EDGAR |
| 2025-12-10 | 4 | Began Marc A — EVP & General Counsel | Sale (S): 9,278 @ $31.21 | EDGAR |
| 2025-12-10 | 4 | DeVinney Erick Wayne — Chief Innovation Officer | Sale (S): 19,517 @ $31.21 | EDGAR |
| 2025-12-10 | 4 | JOHNSON JOHN — Director | Sale (S): 11,802 @ $31.26 · Option exercise (M): 11,891 @ $6.30 · Sale (S): 11,891 @ $31.22 · Option exercise (M): 8,545 @ $6.30 · Sale (S): 8,545 @ $29.98 · Sale (S): 13,141 @ $29.98 · +2 more | EDGAR |
| 2025-12-10 | 4 | DALE MICHAEL D — Chief Executive Officer | Sale (S): 61,463 @ $31.21 | EDGAR |
| 2025-12-10 | 4 | THOMAS PAUL — Director | Sale (S): 21,399 @ $29.61 | EDGAR |
| 2025-12-05 | 4 | Kemp Jens — Chief Marketing Officer | Grant/award (A): 22,500 @ $0 | EDGAR |
| 2025-12-05 | 4 | Began Marc A — EVP & General Counsel | Grant/award (A): 22,500 @ $0 | EDGAR |
| 2025-12-05 | 4 | DeVinney Erick Wayne — Chief Innovation Officer | Grant/award (A): 40,000 @ $0 | EDGAR |
| 2025-12-05 | 4 | DALE MICHAEL D — Chief Executive Officer | Grant/award (A): 150,000 @ $0 | EDGAR |
| 2025-11-13 | 4 | Burke William P. Mr. — Director | Option exercise (M): 19,227 @ $8.14 · Sale (S): 19,227 @ $24.01 · Option exercise (M): 3,591 @ $8.14 · Sale (S): 3,591 @ $24.02 · Option exercise (M): 19,227 (derivative) @ $0 · Option exercise (M): 3,591 (derivative) @ $0 | EDGAR |
| 2025-11-07 | 4 | Burke William P. Mr. — Director | Option exercise (M): 11,431 @ $8.14 · Sale (S): 11,431 @ $24.05 · Option exercise (M): 5,347 @ $8.14 · Sale (S): 5,347 @ $24.01 · Option exercise (M): 11,431 (derivative) @ $0 · Option exercise (M): 5,347 (derivative) @ $0 | EDGAR |
Recent 8-K events — Axogen, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-07-29 | 8-K | 2.02 — Results of Operations and Financial Condition 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-23 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2026-04-28 | 8-K | 2.02 — Results of Operations and Financial Condition 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-02-24 | 8-K | 2.02 — Results of Operations and Financial Condition 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-01-23 | 8-K | 1.01 — Entry into a Material Definitive Agreement 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-01-12 | 8-K | 2.02 — Results of Operations and Financial Condition 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-12-05 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-12-04 | 8-K | 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-10-29 | 8-K | 2.02 — Results of Operations and Financial Condition 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-08-25 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=AXGN returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →